Showing 51-60 of 5685 results for "".
Glaukos Submits NDA for Epi-On CLX Candidate
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-submits-nda-for-epi-on-clx-candidate/37066/Glaukos submits a new drug application to the FDA for its next-generation cross-linking therapy; Regeneron releases phase 3 results for Eylea HD for RVO; and Regeneron acquires a clinical stage biotech making ocular delivery technology for retinal disorders. Learn more about your ad choices. Visit mThe Skinny on Salzmann Nodular Degeneration
https://modernod.com/topics/corneaanterior-segment/the-skinny-on-salzmann-nodular-degeneration/38773/“Elevate” your management of ocular surface disease by checking for this common raised corneal lesion.Special Report: Update on Holland Foundation
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-update-on-holland-foundation/37090/The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease. Learn more about your ad choices. Visit megaphone.fm/adchoicesBreaking News from the ASCRS Meeting in Los Angeles
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-ascrs-meeting-in-los-angeles/37082/EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report – Increasing Access to Care Through the Cure Blindness Project
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-increasing-access-to-care-through-the-cure-blindness-project/37067/Leaders from Cure Blindness Project discuss efforts to restore vision and prevent avoidable blindness in underserved communities around the world. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: OWL Celebrates 20th Anniversary
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-owl-celebrates-20th-anniversary/37060/Executives from Ophthalmic World Leaders discuss the history and goals of thee organization as it celebrates its 20th anniversary. Learn more about your ad choices. Visit megaphone.fm/adchoicesAll-In-One Automated Measurement of Ocular Surface Parameters
https://modernod.com/topics/technology/all-in-one-automated-measurement-of-ocular-surface-parameters/37933/LacryDiag from Quantel Medical simultaneously conducts four essential, noncontact, dye-free exams of the ocular surface for the diagnosis and monitoring of dry eye.Weekly Headlines: Rayner Unveils First AI-Designed Spiral IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08282024/37047/Rayner Unveils First AI-Designed Spiral IOL • Visionix Launches VX 610 Non-Mydriatic Automated Fundus Camera • Injectsense Completes First Human Implant of Ultraminiature IOP SensorNew Practice, Noh Problem: Lessons From Opening a Cold Start Practice
https://modernod.com/podcasts/to-the-point/new-practice-noh-problem-lessons-from-opening-a-cold-start-practice/36932/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome this month’s guest, Ada Noh, OD. Dr. Noh shares her story of how she came to open her very own practice, dedicated solely to dry eye, in a brand new city. She talks about building up her patient base, networking with local provFinally, a Treatment for Demodex Blepharitis
https://modernod.com/videos/eye-care-insiders/sl-are-you-prepared-to-treat-demodex-blepharitis-ph-heres-what-you-need-to-know-about-the-first-fda-approved-treatment-title-finally-a-treatment-for-demodex-blepharitis-the-first-fda-approved-treatment-for-idemodex-blepharitisi/37330/The first FDA-approved treatment for Demodex blepharitis has arrived, and Joseph J. Allen, OD, FAAO, Dipl ABO, reviews what you need to know to start using it in your clinic. He discusses the novel mechanism of action of lotilaner ophthalmic solution 0.25% (Xdemvy, formerly TP-03; Tarsus Pharmaceuti